ES Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Movement Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations Redhill Biopharma RDHL Q2 2022 Earnings Massive EPS Miss Raises Liquidity Concerns XPEL Q1 2026 Earnings Narrow Earnings Beat as Profitability Holds Steady VABK Q1 2026 Earnings EPS of 097 Highlights Steady Performance Amid Limited Disclosure Biomerica Q1 2026 Earnings Net Loss of 044 Per Share Amid Lack of Revenue Disclosure